Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity

QR Code

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity

The article describes prevalence and risk factors of cardiovascular in patients with cancer. The problems of anthracycline-induced cardiotoxicity, the deleterious effects of doxorubicin on the heart, as well as the cardioprotective effects of beta-blockers and agents acting on the renin-angiotensin-...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, I. O. Kudaibergenova, F. A. Yusupov, Zh. A. Murkamilova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-03-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	cancer anthracyclines doxorubicin cardiovascular diseases angina pectoris myocardial infarction troponin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2583
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)

Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01)

High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity
by: V. D. Levina, et al.
Published: (2022-12-01)

INTERACTION OF CYTOKINE CASCADE WITH PSYCHOLOGICAL PROFILE IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-07-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update
by: Vasvi Bhutani, et al.
Published: (2025-05-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

Variations in Prehospital Analgesic Use Based on Pain Etiology
by: Nikolina Marić, et al.
Published: (2025-07-01)

SURGICAL AND ENDOVASCULAR REVASCULARIZATION OF MYOCARDIUM IN MULTIVESSEL DISEASE
by: I. G. Gordeev, et al.
Published: (2016-02-01)

DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST
by: T. Yu. Semiglazova, et al.
Published: (2017-09-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Roles of Non-Coding RNA in Anthracycline Cardiotoxicity: A Narrative Review
by: Xiao S, et al.
Published: (2025-07-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

Clinical features of the course of various forms of acute coronary syndrome in patients with diseases of the upper gastrointestinal tract
by: A. A. Zubareva, et al.
Published: (2024-08-01)

CORONARY HEART DISEASE IN PERSONS OLDER THAN 55 YEARS. PREVALENCE AND PROGNOSIS
by: S. A. Shalnova, et al.
Published: (2014-08-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis
by: Ling Yin Fritz Wong, et al.
Published: (2025-07-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01)

Difficulties of diagnostics of acute myocardial infarction in elderly and senile patients and their influence on management in the acute period of disease
by: O. V. Tukish, et al.
Published: (2019-04-01)

Ejection Fraction Decline and Cardiotoxicity Following Anthracycline Chemotherapy: A Risk-Focused Study from an Indonesian Tertiary Care Center
by: Rizkyastari Onny, et al.
Published: (2025-06-01)

Study the effect of compound Extracted from pomegranate peels and green tea on some biochemical variables in rabbit serum induced with Myocardial Infarction
by: Dhamyaa Wajih Yaqoup, et al.
Published: (2022-12-01)

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS
by: V. I. Chernov, et al.
Published: (2016-12-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

MODERN HIGH-SENSITIVE TROPONIN DIAGNOSTIC METHODS IN ASSESSMENT OF MYOCARDIAL ISCHEMIA AND PROGNOSTICAL VALUE FOR CHRONIC CORONARY HEART DISEASE
by: L. V. Kremneva, et al.
Published: (2017-03-01)

THE INFLUENCE OF VHF ELECTROMAGNETIC RADIATION ON THE FREQUENCIES OF MOLECULAR SPECTRUM AND OXYGEN ABSORPTION ON BLOOD REOLOGICAL PROPERTIES IN STABLE ANGINA
by: V. F. Kirichuk, et al.
Published: (2002-02-01)

The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
by: S. Yu. Martsevich, et al.
Published: (2019-07-01)

COMPARATIVE PROGNOSTIC VALUE OF CREATINE PHOSPHOKINASE MB AND TROPONIN T IN THE DIAGNOSTICS OF PERIPROCEDURAL MYOCARDIAL DAMAGE
by: S. A. Akinina
Published: (2012-06-01)

Cardiovascular system state changes in non-Hodgkin’s lymphoma patients during chemotherapy
by: A.-S. O. Bady, et al.
Published: (2020-05-01)

Aortocoronary Bypass Surgery in Patients with Recurrent Post-Coronary Stenting Angina
by: R. A. Valieva, et al.
Published: (2021-10-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

The relationship between hypertension and angina pectoris; physiological & Biochemical study of patients Samarra city
by: Mostafa A. Abdulrahman
Published: (2023-02-01)

TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR
by: I. M. Sokolov
Published: (2016-01-01)

Acute myocardial infarction-like event in a young patient with biventricular arrhythmogenic cardiomyopathy
by: Y. V. Stavtseva, et al.
Published: (2024-03-01)